Ozyazgan S, Kutluata N, Afsar S, Ozdas SB, Akkan AG: Effect of glucagon-like peptide-1(736) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats
If youre ready to start your weight loss journey with our expert guidance, were here to help
* Safety profile remained generally consistent with previous retatrutide studies
In heart failure patients, there was a lack of changes in cardiac imaging parameters correlates with the lack of impact on outcomes among patients with pre-existing heart failure in major GLP-1 receptor agonist trials
Finally, oral interventions such as orforglipron have demonstrated weight reduction of up to 11.2% at 72 weeks, offering a needle-free alternative for patients with metabolic disease who may prefer oral therapies
A randomized controlled trial in women with androgenetic alopecia found that 57% of PRP-treated patients showed clinical improvement at 24 weeks compared to just 7% in the placebo group, with statistically significant increases in hair density at both 8 and 24 weeks
